GlaxoSmithKline I+D, S.L.
Tres Cantos, Madrid, Comunidad de, Spain
Purpose
to further research intended to increase the efficacy of drug treatment of malaria and ultimately reduce the public health threat posed by malaria in developing countries
Division
Global Health
Date
October 2016
Region Served
GLOBAL
Committed amount
$1,511,994
Grant topic
Discovery and Translational Sciences
Duration (months)
50
Grantee location
Tres Cantos, Madrid, Comunidad de, Spain
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.